Germany
Japan
United Kingdom
China
KRAS mutant (G12D) Myc-DDK-tagged human recombinant protein of Homo sapiens v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), transcript variant b
| Tag | C-Myc/DDK |
Cervical Cancer
View as table Download
Recombinant protein of human major histocompatibility complex, class I, A (HLA-A), 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human phosphatase and tensin homolog (PTEN), 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression lysate of PD-L1 / CD274 molecule (PD-L1 / CD274)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS), transcript variant 1, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human annexin A2 (ANXA2), transcript variant 2, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
CD274 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Purified recombinant protein of mouse PD-L1 / CD274 (PD-L1 / CD274), with C-terminal Fc tag, expressed in human cells, 20 µg
| Tag | C-Fc |
| Expression Host | HEK293T |
KRAS HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
ARID1A HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
TTR HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
MED1 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
PTEN HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Active filters
Expression Hosts
- HEK293T
Citations
- Yes
Filter by
Target Symbol
Species
Tags
Mutants
QC Levels
Families
Pathways
- Endometrial cancer (5)
- Glioma (5)
- Melanoma (5)
- Pathways in cancer (5)
- Prostate cancer (5)
- Tight junction (5)
- Natural killer cell mediated cytotoxicity (4)
- Acute myeloid leukemia (3)
- Axon guidance (3)
- B cell receptor signaling pathway (3)
- Bladder cancer (3)
- Cell adhesion molecules (CAMs) (3)
- Chemokine signaling pathway (3)
- Chronic myeloid leukemia (3)
- ErbB signaling pathway (3)
- Fc epsilon RI signaling pathway (3)
- Focal adhesion (3)
- Gap junction (3)
- GnRH signaling pathway (3)
- Insulin signaling pathway (3)
- Long-term depression (3)
- Long-term potentiation (3)
- MAPK signaling pathway (3)
- Melanogenesis (3)
- Neurotrophin signaling pathway (3)
- Non-small cell lung cancer (3)
- Regulation of actin cytoskeleton (3)
- Renal cell carcinoma (3)
- T cell receptor signaling pathway (3)
- Thyroid cancer (3)
- VEGF signaling pathway (3)
- Colorectal cancer (2)
- Dorso-ventral axis formation (2)
- Endocytosis (2)
- Inositol phosphate metabolism (2)
- Pancreatic cancer (2)
- Phosphatidylinositol signaling system (2)
- Progesterone-mediated oocyte maturation (2)
- Small cell lung cancer (2)
- p53 signaling pathway (2)
- Allograft rejection (1)
- Antigen processing and presentation (1)
- Autoimmune thyroid disease (1)
- Complement and coagulation cascades (1)
- Graft-versus-host disease (1)
- Type I diabetes mellitus (1)
- Viral myocarditis (1)